retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr $bctx 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks